国际医药卫生导报2011，Vol.17Issue(5)：578-580,3.DOI:10.3760/cma.j.issn.1007-1245.2011.05.025
紫杉醇联合卡铂化疗治疗卵巢癌的临床观察
Combination therapy with paclitaxel and carboplatin for ovarian cancer
摘要
Abstract
Objective To explore the efficacy and safety of combination therapy with paclitaxel and carboplatin for ovarian cancer. Methods 40 patients with ovarian cancer received systemic or intraperitoneal chemotherapy with paclitaxel and carboplatin. The efficacy and adverse reactions of the two therapies were observed. Results Of 40 patients, CR was in 12, PR in 18, SD in 6, and PD in 4, with a total effectiveness rate of 75%. The major adverse reactions included hone marrow suppression, hair lose,nausea, and vomiting, but could be tolerated. Conclusions Combination therapy with paclitaxel and carboplatin for ovarian cancer has a better efficacy with tolerable adverse reactions.关键词
紫杉醇/卡铂/化学治疗/卵巢癌Key words
Paclitaxel/Carboplatin/Chemotherapy/Ovarian cancer引用本文复制引用
卢志文,卢光,黄俭..紫杉醇联合卡铂化疗治疗卵巢癌的临床观察[J].国际医药卫生导报,2011,17(5):578-580,3.
